KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Capital Expenditures (2016 - 2026)

Tenet Healthcare (THC) has disclosed Capital Expenditures for 15 consecutive years, with $180.0 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 4.05% year-over-year to $180.0 million; the TTM value through Mar 2026 reached $1.0 billion, up 17.71%, while the annual FY2025 figure was $1.0 billion, 8.49% up from the prior year.
  • Capital Expenditures hit $180.0 million in Q1 2026 for Tenet Healthcare, down from $364.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $364.0 million in Q4 2025 and bottomed at $132.0 million in Q2 2023.
  • Average Capital Expenditures over 5 years is $213.8 million, with a median of $193.0 million recorded in 2025.
  • Year-over-year, Capital Expenditures fell 28.28% in 2023 and then soared 58.65% in 2024.
  • Tenet Healthcare's Capital Expenditures stood at $290.0 million in 2022, then dropped by 28.28% to $208.0 million in 2023, then surged by 58.65% to $330.0 million in 2024, then grew by 10.3% to $364.0 million in 2025, then tumbled by 50.55% to $180.0 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $180.0 million, $364.0 million, and $280.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.